Dec 31, 2013

ANI Pharmaceuticals Q4 2013 Earnings Report

Total Revenue
$10.5M
Previous year: $5.32M
+97.9%
EPS
$0.35
Previous year: -$1.27
-127.6%
Gross Profit
$7.85M
Previous year: -$907K
-965.2%
Cash and Equivalents
$11.1M
Previous year: $11K
+100854.5%
Free Cash Flow
-$2.89M
Previous year: -$641K
+351.5%
Total Assets
$44.5M
Previous year: $13.7M
+223.7%

ANI Pharmaceuticals

ANI Pharmaceuticals